Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5330 Overpass Rd
Buda, TX 78610Phone+1 737-999-6600
Education & Training
- Baylor College of MedicineFellowship, Gastroenterology, 2012 - 2015
- Baylor College of MedicineResidency, Internal Medicine, 2009 - 2012
- University of Texas Southwestern Medical SchoolClass of 2009
- University of North TexasBS, Biology, 2001 - 2004
- Baylor College of MedicineMS, Clinical Investigation
Certifications & Licensure
- TX State Medical License 2011 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 67 citationsGut Microbe–Mediated Suppression of Inflammation-Associated Colon Carcinogenesis by Luminal Histamine ProductionChunxu Gao, Bhanu P. Ganesh, Zhongcheng Shi, Rajesh Shah, Robert Fultz
The American Journal of Pathology. 2017-10-01 - 64 citationsAutomated coronary calcium scoring using deep learning with multicenter external validationDavid Eng, Christopher G. Chute, Nishith Khandwala, Pranav Rajpurkar, Jin Long
NPJ Digital Medicine. 2021-06-01 - 5 citationsMachine Learning Radiomics Model for Early Identification of Small-Cell Lung Cancer on Computed Tomography Scans.Rajesh Shah, Heather M. Selby, Pritam Mukherjee, Shefali Verma, Peiyi Xie
JCO Clinical Cancer Informatics. 2021-07-15
Lectures
- Updates in Microscopic ColitisMichael E. DeBakey VA Medical Center, Houston TX - 1/1/2017
- Diverticulosis and C. difficile InfectionBaylor College of Medicine, Houston TX - 1/1/2017
- Molecular Microbiology and Gastrointestinal DiseasesOita University, Oita, Japan - 1/2017
- Join now to see all
Grant Support
- Molecular Predictors of Response in Patients with Ulcerative ColitisNIDDK2018–2019
- Microbiota Composition Predicts Response to Vedolizumab in Adult Patients with Moderate to Severe Crohn's DiseaseTakeda Pharmaceuticals2016–2017
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: